Prior to this study no instrument to measure cancer patients’ experience with care had been validated. Differences in the care experience may be related to language, race/ethnicity, age, gender or other factors and are thought to alter outcomes including mortality. The primary objective of this study was to evaluate the strengths and weaknesses of the CAHPS instrument and a cancer-specific supplement in a population-based sample of bladder, leukemia and colorectal cancer survivors in terms of data quality, reliability and validity. Dr. Oakley-Girvan continues to conduct selected follow-up work with the participants in this project.
Ingrid Oakley-Girvan, Ph.D.
Neeraj Arora, Ph.D. (National Cancer Institute)
National Cancer Institute Surveillance, Epidemiology and End Results Program